Atara Biotherapeutics, Inc.
ATRA· Nasdaq
Released May 6, 2020, after the close
10-Q filed May 6, 2020, 36 days after period end · 0001564590-20-021960
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Net Income | -$73.51M | -$66.26M | -$41.44M | -$25.65M |
| EPS Diluted | -$1.20 | -$1.44 | -$1.05 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Atara Biotherapeutics, Inc. · CIK 1604464 · Engraved from SEC EDGAR